‘Celebrity’ Rudy Giuliani received Covid-19 drug unavailable to most Americans
- Rudy Giuliani said he got the same Covid-19 treatment as Donald Trump
- The Regeneron drug is in short supply and not available to most Americans
After being discharged from a premier hospital on Thursday, Rudy Giuliani revealed his treatment for Covid-19 included an experimental drug that is in such short supply that some states have set up lotteries to determine which patients should be lucky enough to receive a dose.
Giuliani, 76, confirmed in a text message to the New York Daily News that he received Regeneron’s monoclonal antibody cocktail during his five-day stay at Georgetown University Hospital in Washington, after testing positive for the virus on Sunday.
In a tweet earlier Thursday, the former New York mayor-turned-personal Trump lawyer said he was also fortunate enough to receive treatment advice from White House doctor Sean Conley.
“I walked in with serious symptoms. I walked out better than ever,” Giuliani posted, calling the hospital care “miraculous”.
The Regeneron drug – which Trump also received during his hospitalisation for Covid-19 in October – is not available to most people suffering from the virus that has killed more than 292,000 Americans.
According to tallies from the Department of Health and Human Services, 232,709 courses of the antibody drug had been delivered to hospitals across the US as of Wednesday. By contrast, the US is currently in a phase of the pandemic where it reports more than 200,000 new Covid-19 infections on any given day.
